| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $707.6M | $556.6M | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $563.2M | $446.5M | $0 |
| Gross Margin % | 79.6% | 80.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $260.2M | $183.0M | $153.6M |
| Operating Margin % | 36.8% | 32.9% | — |
| Net Income (GAAP) | $230.5M | $179.8M | $333.9M |
| EBITDA (Normalized) | $281.7M | $207.6M | $153.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $360.0M | $230.6M | $195.8M |
| Capital Expenditures (CapEx) | $26.8M | $30.7M | $0 |
| Free Cash Flow (FCF) | $333.2M | $199.9M | $195.8M |
| FCF Margin % | 47.1% | 35.9% | — |
| Return on Invested Capital (ROIC %) | 16.4% | 12.9% | 3.7% |
| Cash & Short-Term Equivalents | $182.8M | $99.8M | — |
| Total Debt (Short + Long Term) | $74.3M | $100.1M | $1.25B |
| Total Stockholders' Equity | $1.36B | $1.12B | $2.57B |